Prognosis of HTLV-1 positive renal transplant recipients in Iran

Abstract EN

The human T lymphocyte virus-1 (HTLV-1) is the responsible pathogen for diseases such as HTLV-1 associated myelopathy (HAM) and adult T-cell leukemia (ATL).

Mashhad, in northeast Iran, with high instances of this infection, has a noticeable number of infected renal failure patients.

Since immunosuppressive drugs might decrease the latency period of HTLV-1 or increase its complications, the question arises whether HTLV-1 positive renal failure patients are suitable candidates for kidney transplants.

To answer this, HTLV-1 positive recipients were evaluated in our study.

Patients were divided into two groups.

First group consisted of patients at the Imam Reza Hospital dialysis center.

Second group had 20 kidney transplantation recipients consisting of ten infected and ten uninfected recipients as control from Imam Reza.

Medical history of these patients was recorded and evaluated.

The follow-up periods were between one and six years.

Among them, 3.8% of patients undergoing dialysis were infected.

The most important fact resulting from this study is that none of the infected recipients suffered from HAM or ATL during the follow-up period.

In addition, it did not show any significant difference in the incidence of post-transplant complications between the infected and non-infected groups.

Our study indicates that HTLV-1 positive patients may undergo kidney transplant without fear of increased incidence of side effects than those found in uninfected recipients.

Because of short-term follow-up, probable long latency period of the virus, and the limited number of infected recipients, further work on this issue would be prudent.